Morgan Stanley (MS)

Morgan Stanley shares closed at $190.61 on November 11, 2026, up 1.63% on the session, but the stock still sits below its 50-day and 200-day moving averages ($193.70 and $194.44), and the trend reads down. The price is 1.60% below the 50-day SMA of $193.70 and 1.97% below the 200-day SMA of $194.44, so the stock is testing the zone where its longer averages cluster. The company has beaten EPS estimates in all eight of its last eight reports, but the share price has not followed consistently: it fell 2.75% in the first session after the October 14, 2026 report and rose after six of the eight. For investors, the question is whether earnings strength can pull the price back above those averages.

The earnings record is the strongest part of the story. Morgan Stanley beat EPS estimates in all eight of the reports covered, including $3.46 against $2.93 on July 15, 2026, a beat of 18.09%. The most recent beat, $3.03 against $2.92 on October 14, 2026, was 3.77% above the estimate, yet the shares fell 2.75% in the first session afterward. Of the eight reports, six were followed by a higher share price in the first session and two by a lower one. The largest post-report gain came after the January 15, 2026 report, when the stock rose 5.78% on a 9.39% beat.

Revenue grew 27.43% in the latest quarter compared with the same quarter a year earlier, against a sector median of 11.7%. The net profit margin is 24.9% and the operating margin is 39.00%. Return on equity of 18.04% is above the sector median of 13.8%. The debt-to-equity ratio of 4.90 is high on its face, but for a bank it excludes deposits, so it should be read with that in mind.

The trailing P/E of 15.12 is 8.4% below the sector median, which places the stock broadly in line with peers. The price-to-sales ratio of 3.73 is 1.7% below the sector median of 3.8. The trailing dividend yield is 2.26%, from an annual dividend of $4.30 per share. Market capitalisation stands at $297.9B.

Over the last 18 months, insiders sold $89.0M of stock across 21 sales and made one open-market purchase worth $6K. Insider sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than open-market purchases.

The base case is a sideways-to-firm stretch in which the stock works back toward its moving averages while earnings keep growing. Analysts expect EPS to grow 26.4% this fiscal year to $12.91 and 6.1% next year to $13.69, and revenue to grow 16.8% this year to $82.5B. Analysts are split, with 11 of 26 rating the stock buy or strong buy and 14 at hold. The median 12-month target of $206.50 sits 8.3% above the price, and the range runs from $185.00 to $262.00. A move back above the 50-day and 200-day averages would support the bull view. A failure to hold the 20-day EMA, or a slide toward the 52-week low, would signal that the market is not yet paying for the earnings record. Simulation figures are simulations from past volatility, not forecasts; the typical daily move is 2.10%.

Support: the 20-day EMA at $187.14 is the nearest level below the price, and a fall would meet it first. Below that, the 52-week low of $152.80 is the next floor, a level the stock has not revisited in the past year's range. Resistance: the 50-day SMA at $193.70 is the nearest level above the price, and a rise would meet it first. The 200-day SMA at $194.44 is just above it, so the two averages form a single band to clear. Beyond that, the 52-week high of $232.25 marks the top of the range.